Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Not Confirmed
Not Confirmed
27-30 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
KY/TN Water Profession...KY/TN Water Professionals
Industry Trade Show
Not Confirmed
27-30 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
27 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/27/3088667/0/en/HiberCell-Announces-Successful-Completion-of-Dose-Escalation-and-Enrollment-Update-for-Ph1b-Study-Evaluating-HC-7366-in-Combination-with-WELIREG-belzutifan-in-Advanced-ccRCC.html
23 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/23/2967964/0/en/HiberCell-Receives-FDA-Fast-Track-Designation-for-HC-7366-for-the-Treatment-of-Relapsed-or-Refractory-Acute-Myeloid-Leukemia-AML.html
28 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/28/2888943/0/en/HiberCell-Announces-First-Patient-Dosed-in-Phase-1b-Clinical-Trial-Evaluating-HC-7366-in-Combination-with-Venetoclax-and-Azacitidine-for-the-Treatment-of-Acute-Myeloid-Leukemia-AML.html
01 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/01/2873708/0/en/HiberCell-Announces-First-Patient-Dosed-in-Clinical-Collaboration-with-Merck-Evaluating-HC-7366-in-Combination-with-WELIREG-belzutifan-in-patients-with-advanced-ccRCC.html
05 Apr 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/04/05/2858583/0/en/HiberCell-Announces-Recent-Publication-and-Poster-Presentations-for-its-Novel-GCN2-Activator-HC-7366.html
15 Dec 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/12/15/2797135/0/en/HiberCell-Announces-Presentation-at-ASH-Highlighting-Preclinical-Data-for-HC-7366-with-Standard-of-Care-Agents-in-Acute-Myeloid-Leukemia-AML.html
ABOUT THIS PAGE